Here’s my suggestion: if you belong to an HMO, make sure that the Administration and your doctors are very aware of the problem with re-formulation and inconsistency in dosage. This is costing them MONEY, both in terms of additional office visits and in complications in your thyroid management! Let the Managed Care Lobby duke it out with the Pharmaceutical Companies — this ought to speed the process up quite a bit.